Submission Instructions

ENDO 2024 will take place on June 1-4, 2024, in Boston, MA. Please read the following Abstract Submission Guidelines prior to submitting your abstract. If you have any questions not answered within this document, please email [email protected]. 

Abstracts will not be accepted for this submission period beyond the stated deadline of Tuesday, January 9, 2024 at 1:00 PM EST US. Late-breaking abstracts will be accepted March 19 - April 10, 2024.

GENERAL INFORMATION 

Editing Services

Language editing, translation, and poster formatting services are available through American Journal Experts. Endocrine Society members receive additional 10% off. Visit aje.com/go/esmeetings for more information.

Payment

A non-refundable fee of $90.00 USD is due at the time of abstract submission. (Credit Cards and Paypal are accepted). 

Membership

Membership is not a requirement to submit an abstract for ENDO, but Endocrine Society members receive special discounted ENDO registrations rates. You must be an Endocrine Society member to be considered for abstract awards. Join Now to get the best rate for ENDO.

SUBMITTING YOUR ABSTRACT

Submission Steps

You will be prompted to complete the following steps when submitting an abstract: 

Step 1: Abstract Title
Step 2: Presentation Type
Step 3: Science Type and Topic
Step 4: Authors and Disclosures
Step 5: COI and Permissions
Step 6: Abstract Body 
Step 7: Abstract Keywords
Step 8: Submission Questions
Step 9: Awards
Step 10: Payment
Step 11: Review My Work

If you are unable to finish your abstract submission in one sitting, you must at least complete Step 1: Abstract Title, in order to have your submission saved and be able to return to the abstract submission site and complete any time prior to the deadline. All abstracts must be completed and submitted by the abstract submission deadline of Tuesday, January 9, 2024 at 1:00 PM EST US. If you do not complete the submission prior to the deadline, your abstract will not be reviewed.

Step 1: Abstract Title

Abstract titles should be short and specific, and entered in title case (the first letter of each word is capitalized, except for certain small words, such as articles, conjunctions, and prepositions).

For assistance with putting your abstract title in title case, visit www.capitalizemytitle.com. 

Example:

This Is a Properly Formatted Title

Step 2: Presentation Type

You may select your abstract to be considered for an Oral Presentation, Rapid Fire Poster Presentation, or a Traditional Poster Presentation. Please Note: Authors of accepted abstracts will receive further information and technical guidelines on how to prepare for their oral, rapid fire, or poster presentation.

Oral Presentation
The highest-ranked abstracts are selected for Oral Session Presentations. These sessions will take place in Boston, June 1-4, 2024. Presenting authors will have dedicated time to give a 10-minute presentation using slides to summarize their abstract followed by a brief 3-5 minute question and answer session. Note: Abstracts not accepted for an Oral Presentation will automatically be considered for Rapid Fire Poster Presentations.

Rapid Fire Presentation
Rapid Fire Poster Presentations will take place in Boston, June 1-4, 2024. Presenting authors will give a 2-5-minute presentation with no more than 5 slides, highlighting the key points, so interested attendees can ask questions about your work in the subsequent communications. Select this option if you do not wish to be considered for an oral presentation and want to provide a quick synopsis of your work. The Rapid Fire Poster Presentations will be delivered in session rooms prior to oral abstract presentations.

Traditional Poster Presentation (Printed Poster)
Poster Presentations will take place in-person in Boston, Saturday, June 1, 2024, through Monday June 3, 2024. Presenting authors will be able to display a traditional poster on an expansive poster floor. Poster presenters will be assigned one day to display their printed poster at the conference. In addition, poster presenters will be able to stand next to their printed poster during a Meet-and-Greet session. Presenting authors will bring their poster to be presented in the exhibit hall and receive comments and questions on their poster(s) from meeting participants. Select this option if you do not wish to be considered for an oral or rapid-fire presentation and want to take advantage of presenting your work in the poster hall. 

Step 3: Science Type and Topic

Basic, clinical, translational scientific abstracts, and clinical trials are accepted for submission across over 100 topical areas, and clinical case reports are accepted for submission in 16 topical areas. View the complete list of 2023 Abstract Topical Areas.

• Basic Scientific Research - Submissions should report basic endocrine research (e.g., physiological or molecular biological research in cell cultures or animal models). 
• Translational Scientific Research - Submissions should report mechanistic endocrine research in humans, human tissues, tumor cells, or animal models that have a direct relationship to human physiology or disease.
• Clinical Scientific Research - Submissions should report endocrine research investigating or concerning specific disease states (e.g., evaluation of diagnostic techniques and therapies).
• Clinical Trial - Submissions should report data about the safety or potential benefit of an endocrine intervention such as a medication, device, teaching concept, training method, or behavioral change in human subjects.
• Clinical Case Report - Submissions should report valuable/novel teaching points or learning lessons from clinical care of endocrine disorders. In addition to consideration for presentation at ENDO, clinical case reports will be considered for use in other educational formats, online or in print.

For detailed information on submitting abstracts view: 

• Submitting a Scientific Abstract
• Submitting a Case Report Abstract
• Submitting a Clinical Trial Abstract

Step 4: Authors and Disclosures

Authors
Edits to authors will not be accepted after the abstract submission site has closed. Please review this information carefully to ensure you have included all authors. You may also change the presenting author here at any time up until the abstract submission site closes (NOTE: There can be only one Presenting Author in your submission). 

Enter contact information and disclosures for the presenting author. Based on the disclosures entered for the presenting author, complete the Conflict of Interest (COI) resolution and recording permissions. If you change the presenting authors, you must also update the COI and permissions pertinent to the new presenting author.

Disclosures
FACULTY DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS & RESOLUTION OF CONFLICTS OF INTEREST

In accordance with requirements of the Accreditation Council for Continuing Medical Education (ACCME), the Endocrine Society requires all individuals who are in a position to control the content of a CME activity to disclose all financial relationships with any commercial interest that produces, markets, resells, or distributes healthcare goods or services consumed by or used on patients.

Financial relationships are defined as remuneration paid to you in any amount that has occurred within the last 24 months when these two conditions apply:

• You have financial relationship with a commercial interest
• You have the opportunity to affect CME content related to the products or services of that commercial interest

If a potential conflict of interest exists as a result of a financial relationship, this will need to be resolved prior to the activity. All financial relationships must be disclosed to learners at the beginning of the CME activity. If no financial relationships exist, learners must be informed of that as well.

Step 5: COI and Permissions

Conflict of Interest
If you listed a conflict of interest for your abstract presentation when you completed your disclosures and a potential conflict exists as a result of a financial relationship, this will need to be resolved prior to the activity. Please complete this step to assist with resolving any potential conflict of interests so that the Endocrine Society may provide CME on your presentation.

Session Recording Permissions
The Endocrine Society will record oral abstract presentations, with your consent and will make the recording available through Endocrine Society distribution channels. In this section, please select your options and provide requested information.

Step 6: Abstract Body

• Character Limit: Maximum of 2,500 characters, including punctuation (not spaces), for the text of your abstract body. Figures, tables, graphs will not be accepted. References are allowed but not required and should be included in the body of your abstract. If you include references, they will count toward the 2,500-character limit.
• Abstract Body: Select "Enter Abstract Text" below to type in your abstract or copy and paste it from an existing document, or "Upload a File Containing Your Abstract". To preserve formatting and scientific characters in your abstract text, uploading a file containing your abstract is the preferred option. You may upload any .doc or .docx file, but the total character limit must not exceed 2,500. PLEASE NOTE: To preserve the blind peer review process, do not include any identifying information (institution or author names) in your abstract. All co-authors/primary investigators, their institutional affiliations, and any disclosures must be entered in Step 4: AUTHORS AND DISCLOSURES.
• Graphics (e.g., figures and tables) are not accepted in the body of your abstract.

IMPORTANT: Please carefully review your abstract and author information before finalizing your submission. Presenting authors may edit their abstract by returning to the abstract submission site at any time prior to the submission deadline. No edits can be made once the submission site closes. Accepted abstracts will be published online in the ENDO program, in the ENDO mobile app (if applicable), and in the Journal of the Endocrine Society (JES). Authors will not have an opportunity to review or approve proofs of their abstract before it appears online and in JES, and corrections after publication in JES are not possible.

Step 7: Abstract Keywords

Keywords help others search for and find your abstract when using the ENDO 2024 Meeting Platform. Select keywords from a drop-down menu that would likely be used to search for your abstract. Minimum of 1 keyword and maximum of 3 keywords.

Please carefully review your abstract and author information before clicking the "Save and Continue" button. Make any edits if necessary.

Step 8: Submission Questions

• Question 1: Principal Investigator – provide the PI of your research
• Question 2: Religious Conflicts – indicate if any conflicts exist which would prevent you from presenting on certain days (Saturday or Sunday)
• Question 3: Embargo and Publication Restriction – indicate if you do not want your full abstract posted online until the date of your presentation.
• Question 4: Quality Improvement and Patient Safety – Indicate if abstract covers quality improvement and patient safety.
• Question 5: Rising Star Power Talks – Allows the submitter to opt-in to being considered for a Rising Star Power Talk session.  Rising Star Power Talks are a competitive style of oral presentations at ENDO that focuses on the big-picture relevance of fundamental endocrine research. The sessions will feature basic and clinical science trainees and early career members with top-scoring abstracts. Speakers will be expected to emphasize and clearly communicate the significance of their research to a general audience. Each presentation will be three minutes followed by a two-minute Q&A, and presenters will only be allowed one PowerPoint slide. Audience members will vote on their favorite presentation along with the judges, and the winners will receive complimentary registration to ENDO 2025.

Step 9: Awards (Optional)

The Endocrine Society provides awards to recognize outstanding work in endocrinology. These recognition awards are given to outstanding abstracts submitted by in-training fellows and new faculty whom who have been accepted to present their research during the annual meeting (ENDO). Please visit endocrine.org/awards for award criteria and more information.

Each award will have varying criteria. Please visit ENDO Awards to learn more. Winner selection for all awards is based on award criteria and abstract score.

Standard Award Requirements:

• You MUST be the first and presenting author on the abstract submission
• You MUST be currently in-training (Graduate Student, Medical School Student, Clinical or Post-Doctoral Fellow) or early career junior faculty (within 3 years of completing your fellowship and/or 1st - 2nd year of appointment)
• You MUST be an Endocrine Society member to be considered for an abstract-based award. Learn more about the benefits of membership, including discounted ENDO registration, at endocrine.org/membership. 

Step 10: Payment

The ENDO 2024 abstract fee is $90 (USD) per abstract. Abstract fees are non-refundable. Visa, Master Card, and American Express are accepted. Note: Paying the abstract submission fee does not register you for ENDO 2024. All abstract presenters must register to attend ENDO 2024. Please visit endocrine.org/endo2024 for registration information.

If you are having difficulty finalizing your payment, please contact [email protected] or by phone at +1 (217) 398-1792.

Step 11: Review My Work

Please carefully review your abstract and author information before the abstract submission site closes. No edits can be made once the submission site closes. Accepted abstracts will be published online in the ENDO program, in the ENDO mobile app, and in the Journal of the Endocrine Society (JES). Authors will not have an opportunity to review or approve proofs of their abstract before it appears online and in JES, and corrections after publication in JES are not possible. 

You will receive an email confirming your submission. Return to the submission site at any time before the submission deadline to make edits to your abstract. All abstracts must be completed and submitted by the abstract submission deadline, Tuesday, January 9, 2024 at 1:00PM ET US. If you do not complete the submission prior to the deadline, your abstract will not be reviewed.

Please make all changes before the abstract submission site closes. No edits can be made to your abstract after the submission site closes.

AFTER YOUR ABSTRACT HAS BEEN SUBMITTED

Edits
Submitting (contact) authors may use the link provided through their submission confirmation email to edit their abstract up until the abstract submission deadline. NO REVISIONS to the abstract or the list of authors will be allowed once the site closes on the deadline date. 

Abstract Withdrawal
Abstracts may be withdrawn by sending an email to [email protected]. Withdrawal requests must be submitted by the submitting (contact) author and include the abstract submission confirmation number. The $90 abstract submission fee is not refundable.

Notice of Abstract Acceptance 
Abstract notifications will be emailed to presenting authors and co-authors in late-February.

Abstract Sessioning
Authors of accepted abstracts will receive presentation details, information and technical guidelines on how to prepare for their oral or poster presentation. Presenting authors will not be allowed to reschedule their presentation except for religious reasons (as identified in Step 8 of the submission process).

Abstract Publication
All accepted abstracts from registered presenters will be published on the meeting website and in a supplemental issue of the Open Access Journal of the Endocrine Society (JES) and assigned a DOI.